Viridian Therapeutics: The Song Remains The Same

Live Chat on The Biotech Forum has been dominated by discussion of lucrative buy-write or covered call opportunities on selected biotech stocks over the past several months. To see what I and the other season biotech investors are targeting as trading ideas real-time, just join our community at The Biotech Forum by clicking HERE .Today, I put Viridian Therapeutics, Inc. (NASDAQ: VRDN ) in the spotlight for the first time in 2025. Despite the lack of major news flow around this promising clinical-stage biote ...